首页> 外文OA文献 >Background and Update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer

【2h】

Background and Update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer

机译：S1602的背景和更新“A III期随机试验，以评估BCG菌株和T细胞引发与皮内BCG在BCG-Naïve高档非肌肉侵袭性膀胱癌中的膀胱内部BCG对C细胞引发的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Robert S. Svatek; Cathy Tangen; Scott Delacroix; William Lowrance; Seth P. Lerner;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301) [J] . Dickon Hayne, Martin Stockler, Steve P. McCombie, BMC Cancer . 2015 ,第1期

机译：BCG + MMC试验：在BCG中添加丝裂霉素C作为高危，无肌肉浸润性膀胱癌的辅助膀胱内治疗：一项随机III期试验（ANZUP 1301）
2. Re: Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: Results from a prospective randomized phase III trial [J] . WoodD.P. The Journal of Urology . 2013 ,第2期

机译：回复：非肌肉浸润性膀胱癌患者中，使用匙孔lim血蓝蛋白与膀胱内丝裂霉素进行皮内和膀胱内免疫治疗的比较：一项前瞻性随机III期试验的结果
3. Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: Results from a prospective randomized phase III trial [J] . LammersR.J.M., WitjesW.P.J., Janzing-PastorsM.H.D., Journal of Clinical Oncology . 2012 ,第18期

机译：非肌肉浸润性膀胱癌患者中，使用钥孔lim血蓝蛋白与膀胱内丝裂霉素进行皮内和膀胱内免疫治疗与丝裂霉素相比：前瞻性随机III期试验的结果
4. Background and Update for S1602 A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer [O] . Robert S. Svatek, Cathy Tangen, Scott Delacroix, -1

机译：S1602 III期随机试验以评估BCG初治非高度侵袭性膀胱癌的膀胱内治疗之前用皮内BCG评估BCG株差异和T细胞启动的影响的背景和更新
5. BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301) [O] . 2015

机译：BCG + MMC试验：在BCG中添加丝裂霉素C作为高危，无肌肉浸润性膀胱癌的辅助膀胱内治疗：一项随机III期试验（ANZUP 1301）

Background and Update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer

著录项

相似文献

相关主题

期刊订阅